Latest news with #Everts
CBC
27-04-2025
- Health
- CBC
Whole-body deodorant is no fix for accepting that everybody stinks sometimes
As the weather warms up and we start to spend more time outdoors, many of us will be reminded that people have a tendency to smell. Pharmaceutical companies have tried for years to convince people to purchase products that cover up their smells, even introducing deodorant for the whole body. "We all have B.O.," Sarah Everts, a Carleton University associate professor and author of The Joy of Sweat: The Strange Science of Perspiration, told Dr. Brian Goldman, host of The Dose podcast. While pharmaceutical companies continue to market products aimed at encouraging people to cover up their natural scents and help stop sweating, experts say that body odour and sweat are perfectly natural and people shouldn't worry about them quite so much. Why do we sweat? University of Calgary kinesiologist Patricia Doyle-Baker said sweating is a response to the environment. "[Sweating] is a biological advantage, because we can do any type of exercise or be in a hot environment and our body is able to thermoregulate itself," she said. Both Doyle-Baker and Everts describe sweating as a kind of evolutionary "superpower," because our bodies provided us with a mechanism to rapidly cool down after explosively bouts of exercise. "We are better than any other animal at cooling down," said Everts. Sweating happens when the skin sends signals to the brain indicating that the body is getting hot, triggering sweat glands to release a liquid mixture of mostly water, as well as salt, potassium and carbohydrates. The beads of water that form on our skin evaporate, cooling us down. That said, the sweat generated by the endocrine glands on our skin is a little different than the sweat produced by the apocrine glands in our armpits or groins. The kind from our armpits and groins are a little fattier, which is part of what leads to the unique mixture of scents we sometimes call body odour — especially when combined with bacteria on our skin. "Although we think of sweat as being odourless, when it mixes with that bacteria, that's what produces the smell," said Doyle-Baker. How do we smell? Dr. Johannes Frasnelli, a psychologist from Université du Québec à Trois-Rivières, says even the most basic single-cellular organism needs a way to sense its environment. "Let's say there's a sugar present, well then they'd rather go there. Some toxins present, well then they'd rather move away. And we basically do the same thing," he said. Frasnelli says both our senses of smell and taste are essential for maintaining our airways, our gastrointestinal system and the rest of the body. Humans are able to smell thanks to our olfactory systems, which allow our noses to identify inhaled molecules and transmit that information to our brains through electrical signals. WATCH | The truth about vaginal detoxing: The truth about vaginal detoxing 5 years ago Duration 4:22 Health Canada has stopped the sale of a natural health care product that is marketed as a way to "detox" vaginas, following an investigation by CBC's Marketplace. Our investigation found that Goddess Vaginal Detox Pearls' claims of cleansing and healing from sexual trauma could lead to serious mental and physical health impacts. Olfactory information is also processed through the limbic system, the part of the nervous system that's responsible for things like memory. "So when we smell something, the brain areas that are involved in memory formation, in memory retrieval, that are involved in emotions, that are involved in reward, are directly activated," said Frasnelli. The relationship between smell and memory is part of the reason why certain smells can make us feel like we've travelled through time, remembering moments when we first encountered them. Why do we smell? Frasnelli says our armpits, genitals and buttocks produce a mix of things that are distinct from person to person. "This cocktail of substances is not entirely understood yet what exactly is in it, but we know that this cocktail is individually different between all of us," he said. At the same time, he says that body odour is affected by a number of factors, including the foods we eat, meaning that eating foods with distinct aromas will sometimes make us smell like them. "We can very well imagine that different cultures eat different things and will therefore smell different because of that," said Frasnelli. Exploring the cultural factor Despite what some might believe, there are very few universally agreed upon bad smells. According to Frasnelli, multiple factors play into our like or dislike of scents, including how strong it is, as well as how long we smell it, and even the emotions surrounding a smell. A person's reaction to body odour, for instance, can be determined by how familiar they are with a certain smell. Familiar scents can be attractive to us, but scents that are too familiar can protect us from accidentally pursuing a mate who is related to us. Speaking from personal experience, Frasnelli added that different cultures have different views on body odour. " I grew up in Europe, and I've been living in North America and Canada now for 20 years, and I can definitely confirm that the rules around body hygiene are different," he said. "What is acceptable as body odour in the parts of Europe where i grew up are not acceptable in the part of of North America." The pitfalls of too much deodorant Dr. Renee Beach, a Toronto dermatologist, said there are potential social and medical downsides to wearing too much deodorant to mask our natural scent. "The risk socially is smelling like a walking perfume factory," said Beach in an email to CBC. "This is brutal in certain close encounter situations like elevators, medical appointments." Though not quite deodorant, French President Emmanuel Macron's alleged overuse of cologne generated headlines after an author claimed that aides could smell the politician before he walked into the room. Medically speaking, wearing deodorant risks irritating skin, especially skin that's inflamed or broken, said Beach. Beach says the risk of skin allergy isn't dependent on the amount worn, but on the ingredients in the deodorant. However, she cautions against using whole-body deodorant. Instead, she says showering regularly with soap and water should suffice in maintaining good hygiene. "In particular, the concept of intimate skin deodorant/body perfume is not only unnecessary for the vast majority of us, but potentially irritating to our skin and in our intimate areas," said Beach. "Unfortunately some of the advertising around this concept has preyed upon our insecurities and fears of having odour when body scents are completely natural and, again, often sufficiently controlled with daily bathing."
Yahoo
09-03-2025
- Yahoo
Former LASD jailer pleads no contest to sex crimes against inmate
A former Los Angeles County Sheriff's Department custody assistant pleaded no contest to committing sex crimes against an inmate in a Lancaster jail cell in 2019. The district attorney announced the plea Friday and said that prosecutors will push for a maximum eight-year sentencing for the alleged attack. 'What happened to the victim in this case is unconscionable, and our office will not tolerate such egregious abuses of authority,' Dist. Atty. Nathan J. Hochman said in a statement. 'A member of law enforcement who commits sex crimes against an inmate in their custody deserves to be imprisoned. Our prosecutors will vigorously argue for the maximum sentence in state prison.' The woman who Daniel Everts, now 30, allegedly assaulted filed a federal lawsuit against the Sheriff's Department and Los Angeles County in 2019. The case settled for $950,000 two years later. In her suit, the woman said she was booked into the Lancaster station jail in June 2019 for driving under the influence, and claimed that Everts assaulted her after she asked for a blanket. Everts warned her that she 'could do more time in custody and remain in custody if she did not comply' with his demands, the suit alleges, before he entered her jail cell, lowered his pants and forced her to perform oral sex. The woman was released the next day and Everts was arrested days later before his release on $100,000 bail. Everts was charged with three felonies for forcible oral copulation, oral copulation under threat of arrest and sexual activity with a detained inmate. He originally pleaded not guilty, but this month entered an open plea of no contest to all counts. The case was investigated by the Sheriff's Department. Sentencing is scheduled for July 7. Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week. This story originally appeared in Los Angeles Times.
Yahoo
09-03-2025
- Yahoo
Former LASD jailer pleads no contest to sex crimes against inmate
A former Los Angeles County Sheriff's Department custody assistant pleaded no contest to committing sex crimes against an inmate in a Lancaster jail cell in 2019. The district attorney announced the plea Friday and said that prosecutors will push for a maximum eight-year sentencing for the alleged attack. 'What happened to the victim in this case is unconscionable, and our office will not tolerate such egregious abuses of authority,' Dist. Atty. Nathan J. Hochman said in a statement. 'A member of law enforcement who commits sex crimes against an inmate in their custody deserves to be imprisoned. Our prosecutors will vigorously argue for the maximum sentence in state prison.' The woman who Daniel Everts, now 30, allegedly assaulted filed a federal lawsuit against the Sheriff's Department and Los Angeles County in 2019. The case settled for $950,000 two years later. In her suit, the woman said she was booked into the Lancaster station jail in June 2019 for driving under the influence, and claimed that Everts assaulted her after she asked for a blanket. Everts warned her that she 'could do more time in custody and remain in custody if she did not comply' with his demands, the suit alleges, before he entered her jail cell, lowered his pants and forced her to perform oral sex. The woman was released the next day and Everts was arrested days later before his release on $100,000 bail. Everts was charged with three felonies for forcible oral copulation, oral copulation under threat of arrest and sexual activity with a detained inmate. He originally pleaded not guilty, but this month entered an open plea of no contest to all counts. The case was investigated by the Sheriff's Department. Sentencing is scheduled for July 7. Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week. This story originally appeared in Los Angeles Times.
Associated Press
18-02-2025
- Business
- Associated Press
ZEO ScientifiX Strengthens Leadership Team With The Appointment of Dr. Peter Everts as Chief Scientific and Technology Officer
FORT LAUDERDALE, FL / ACCESS Newswire / February 18, 2025 / ZEO ScientifiX, Inc. ('ZEO' or the 'Company') (OTCQB:ZEOX), a clinical-stage biopharmaceutical company focused on the research and development of innovative biological therapeutics for the treatment of degenerative diseases and regenerative medicine and the development and sales of biologic products used in topical aesthetic applications, today announced that it has appointed Peter A. M. Everts, Ph.D., as the Company's Chief Scientific and Technology Officer. Dr. Everts has built a distinguished career of over 35 years as a clinician, researcher, and executive, with specialized expertise in medical devices and biological therapies used in orthobiology-msk, spine, chronic wound care, cardiac surgery, reconstructive surgery, facial aesthetics, hair regrowth, and other regenerative medicine applications. Prior to joining ZEO, Dr. Everts served as Chief Scientific Officer at EmCyte Corporation and Educational Program Director at Gulf Coast Biologics, where he led research and development efforts focused on autologous biological protocols to improve patient outcomes in musculoskeletal and spine disorders. In 2010, Dr. Everts co-founded the Da Vinci Clinic in the Netherlands, where he served as Chairman of the Board of Directors, specializing in hyperbaric medicine and advanced biological therapies for complex chronic wound care. He also held senior leadership roles at Avance Medical (Switzerland), directing regenerative medicine and cell therapies for European and Middle East markets. His international collaborations with universities and research centers have contributed to significant advancements in the field. Dr. Everts earned his Ph.D. in Medicine from the University of Utrecht, the Netherlands, and currently holds an Adjunct Professorship at the University of Queensland, Brisbane (Australia) and an International Professorship at Max Planck University, Indaiatuba (Brazil). Dr Everts commented, 'the opportunity to join the ZEO team is both exciting and rewarding as ZEO is committed to advancements in innovative biological therapeutics for regenerative medicine, based on safety and evidence-based data.' 'We are excited to welcome Dr. Everts to the ZEO ScientifiX™ leadership team,' said Ian Bothwell, Interim CEO and CFO of ZEO. 'His vast experience and leadership will be instrumental as we continue to develop innovative biologic therapeutic products and seek to advance our clinical trial portfolio.' In addition, Mr. Bothwell added, 'this strategic addition to ZEO's executive team underscores the Company's commitment to accelerating innovation, enhancing patient outcomes, and expanding the commercial potential of regenerative therapies. As investors seek to capitalize on the exponential growth of the biologic medicine industry, we believe that Dr. Everts' leadership will play a pivotal role in guiding the Company's scientific advancements and reinforcing its market position'. About ZEO ScientifiX, Inc. ZEO ScientifiX is a clinical-stage biopharmaceutical company primarily focused on developing innovative biological therapeutics for regenerative medicine and the treatment of degenerative diseases. We are driven by a commitment to advance the frontiers of regenerative medicine and biologic therapeutics, delivering meaningful solutions for patients and providers worldwide. Our proprietary products, including (a) Zofin™, which are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles and (b) Patient Pure X™ ('PPX™"), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient's own peripheral blood. During November 2024, the Company announced that it was launching the first planned collaborative product with Exotropin; 'ZEO HAIR GROW™ Powered By Exotropin™", a proprietary topical physician formulated hair regrow system. The Company's proprietary products are manufactured in an FDA-registered, cGMP-compliant laboratory. To learn more, please visit Forward-Looking Statements Certain statements contained in this press release should be considered forward-looking statements within the meaning of the Securities Act of 1933, as amended (the 'Securities Act'), the Securities Exchange Act of 1934, as amended (the 'Exchange Act'), and the Private Securities Litigation Reform Act of 1995. These forward-looking statements are often identified by the use of forward-looking terminology such as 'will,' 'believes,' 'expects,' 'potential,' or similar expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect. No assurances can be given that the Company will be successful in its research initiatives. In addition, no assurances can be given that our research initiatives will increase the price of our common stock to a level that is attractive to brokerage houses and institutional investors. We remind you that actual results could vary dramatically as a result of known and unknown risks and uncertainties, including but not limited to: potential issues related to our financial condition, competition, the ability to retain key personnel, product safety, efficacy and acceptance, the commercial success of any new products or technologies, success of clinical programs, ability to retain key customers, our inability to expand sales and distribution channels, legislation or regulations affecting our operations, including product pricing, reimbursement or access, the ability to protect our patents and other intellectual property both domestically and internationally, and other known and unknown risks and uncertainties, including the risk factors discussed in the Company's periodic reports that are filed with the SEC and available on the SEC's website ( You are cautioned not to place undue reliance on these forward-looking statements. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these risk factors. Specific information included in this press release may change over time and may or may not be accurate after the date of the release. ZEO has no intention and specifically disclaims any duty to update the information in this press release. 1-888-963-7881
